Transgene SA (TNG.PA)
EUR 0.71
(-1.8%)
EUR 0.71
(-1.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -34.96 Million | -20.3 Million | -31.94 Million | -28.74 Million | -22.41 Million | -28.38 Million |
| Net Income | -22.32 Million | -32.8 Million | -19.53 Million | -17.23 Million | -18.8 Million | 8.02 Million |
| Depreciation & Amortization | 1.58 Million | 1.68 Million | 2.52 Million | 1.78 Million | 770 Thousand | 1.73 Million |
| Deferred income taxes | -9.69 Million | - | -1.03 Million | 722 Thousand | 993 Thousand | -2.67 Million |
| Stock-based compensation | 290 Thousand | 2.67 Million | 4.65 Million | 1.74 Million | 1.35 Million | 467 Thousand |
| Change in working capital | -7.06 Million | 5.09 Million | -12.79 Million | -8.68 Million | -1.13 Million | -2.35 Million |
| Other non-cash items | 2.24 Million | 3.05 Million | -4.1 Million | -7.08 Million | -5.58 Million | -33.57 Million |
| Investing Cash Flow | 34.57 Million | 20.27 Million | 16.79 Million | 17.74 Million | -531 Thousand | -1.39 Million |
| Investments in PPE | -2.74 Million | -1.53 Million | -686 Thousand | -852 Thousand | -1.73 Million | -1.4 Million |
| Acquisitions | 14.34 Million | - | 17.19 Million | 18.22 Million | - | - |
| Investment purchases | - | - | -40 Million | -18.59 Million | - | - |
| Sales/Maturities of investments | 37.31 Million | 21.8 Million | 17.47 Million | 18.59 Million | 1.2 Million | 6000.00 |
| Other Investing Activities | -14.34 Million | 21.76 Million | 22.8 Million | 370 Thousand | 1.2 Million | 6000.00 |
| Financing Cash Flow | 11.66 Million | -1.47 Million | 15.77 Million | 14.94 Million | 22.4 Million | 30.02 Million |
| Debt repayment | -12.85 Million | -1.28 Million | -197 Thousand | -11.4 Million | -2.37 Million | -466 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 34.12 Million | - | 48.71 Million | - |
| Other Financing Activities | 12.85 Million | -191 Thousand | -18.16 Million | 26.34 Million | -23.93 Million | 30.02 Million |
| Accounts receivables | -3.76 Million | 7.1 Million | -14.77 Million | -5.45 Million | -7.88 Million | -3.63 Million |
| Accounts payables | -2.46 Million | -750 Thousand | 2.65 Million | -2.05 Million | 2.27 Million | 2.03 Million |
| Inventory | - | - | - | - | 443 Thousand | -173 Thousand |
| Other working capital | -832 Thousand | -1.26 Million | -683 Thousand | -1.16 Million | 4.03 Million | -2.18 Million |
| Cash at beginning of period | 4.4 Million | 5.91 Million | 5.27 Million | 1.34 Million | 1.88 Million | 1.64 Million |
| Cash at end of period | 15.66 Million | 4.4 Million | 5.91 Million | 5.27 Million | 1.34 Million | 1.88 Million |
| Capital Expenditure | -2.74 Million | -1.53 Million | -686 Thousand | -852 Thousand | -1.73 Million | -1.4 Million |
| Effect of forex changes on cash | -7000.00 | - | 12 Thousand | -7000.00 | 1000.00 | 1000.00 |
| Net cash flow / Change in cash | 11.26 Million | -1.5 Million | 634 Thousand | 3.93 Million | -542 Thousand | 242 Thousand |
| Free Cash Flow | -37.71 Million | -21.83 Million | -32.62 Million | -29.59 Million | -24.14 Million | -29.78 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.48 Million | -3.21 Million | -22.32 Million | -3.21 Million | -15.9 Million | -7.95 Million |
| Depreciation & Amortization | 606 Thousand | 386 Thousand | 1.58 Million | 386 Thousand | 803 Thousand | 400 Thousand |
| Deferred income taxes | - | - | -9.69 Million | - | - | - |
| Stock-based compensation | - | 148 Thousand | 290 Thousand | 148 Thousand | -3000.00 | -3000.00 |
| Change in working capital | -2.86 Million | -458 Thousand | -7.06 Million | -458 Thousand | -4.04 Million | -1.36 Million |
| Other non-cash items | 611 Thousand | -5.36 Million | 2.24 Million | -5.36 Million | 5.93 Million | 93 Thousand |
| Investing Cash Flow | -1.44 Million | 8.33 Million | 34.57 Million | 8.33 Million | 17.89 Million | 8.94 Million |
| Investments in PPE | -2 Million | -632.5 Thousand | -2.74 Million | -632.5 Thousand | -1.43 Million | -701 Thousand |
| Acquisitions | - | - | 14.34 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 567 Thousand | 17.98 Million | 37.31 Million | - | 19.33 Million | - |
| Other Investing Activities | - | 8.96 Million | -14.34 Million | 8.96 Million | 9.65 Million | 9.65 Million |
| Financing Cash Flow | 18.83 Million | 6.14 Million | 11.66 Million | 6.14 Million | -914 Thousand | -457 Thousand |
| Debt repayment | - | - | -12.85 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 18.83 Million | 6.14 Million | 12.85 Million | 6.14 Million | -304 Thousand | -457 Thousand |
| Accounts receivables | -3.93 Million | 829 Thousand | -3.76 Million | 829 Thousand | -2.43 Million | 532 Thousand |
| Accounts payables | 2.36 Million | -2.05 Million | -2.46 Million | - | -410 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.29 Million | -1.28 Million | -832 Thousand | -1.28 Million | -1.2 Million | -1.9 Million |
| Cash at beginning of period | 15.66 Million | 3.72 Million | 4.4 Million | - | 4.4 Million | - |
| Cash at end of period | 15.32 Million | 15.66 Million | 15.66 Million | 5.97 Million | 3.72 Million | -341.5 Thousand |
| Capital Expenditure | -2 Million | -632.5 Thousand | -2.74 Million | -632.5 Thousand | -1.43 Million | -701 Thousand |
| Effect of forex changes on cash | - | 1.00 | -7000.00 | - | -3500.00 | -3500.00 |
| Net cash flow / Change in cash | -346 Thousand | 11.94 Million | 11.26 Million | 5.97 Million | -683 Thousand | -341.5 Thousand |
| Free Cash Flow | -20.13 Million | -9.13 Million | -37.71 Million | -9.13 Million | -19.09 Million | -9.53 Million |
5186
5344
603256
0235
HINDUNILVR
PFXNZ